Literature DB >> 8862276

Development of T-cell lines expressing functional HIV-1 envelope glycoproteins for evaluation of immune responses in HIV-infected individuals.

T Keler1, H Li, M W Cloyd, L A Vitale, Y M Deo.   

Abstract

The human T-lymphoid cell line, CEM, was transfected with gp 160 cDNA of human immunodeficiency virus type 1 (HIV-1)pm213. Three clones expressing the envelope glycoproteins (env), designated CEM-213env1, -env4, and -env7, were isolated. These clones expressed high levels of surface gp41 and gp120, as demonstrated by flow cytometry with anti-HIV env monoclonal antibodies. Processing and function of env was shown by induction of syncytia with CD4-expressing HeLa cells and by immunoblot analysis. The env expression resulted in specific down-regulation of surface CD4 levels, supporting the role of HIV env in CD4 modulation. Furthermore, serum samples from nine of nine HIV-1-infected individuals bound specifically to the env-expressing transfectants, substantiating the presence of conserved antigenic determinants. These sera also mediated antibody-dependent cellular cytotoxicity (ADCC) of the env-expressing cell lines. The env-expressing cell lines provide a relevant, safe, and practical model for qualitative and quantitative analysis of humoral and cellular immune responses and their role in HIV-1 pathogenesis and therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8862276     DOI: 10.1097/00042560-199610010-00002

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  2 in total

1.  The HIV-1 viral synapse signals human foreskin keratinocytes to secrete thymic stromal lymphopoietin facilitating HIV-1 foreskin entry.

Authors:  Z Zhou; L Xu; A Sennepin; C Federici; Y Ganor; D Tudor; D Damotte; N Barry Delongchamps; M Zerbib; M Bomsel
Journal:  Mucosal Immunol       Date:  2017-04-26       Impact factor: 7.313

2.  Loss of infectivity of HIV-1 particles produced by mobile lymphocytes.

Authors:  Maxime Chazal; Patrycja Nzounza; Claudine Pique; Bertha Cecilia Ramirez
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.